Charles River Laboratories CRL Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value

Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value at other companies

CHE

ChemedCHE

85.8-25.1%

BeldenBDC

$39.44+80.5%

RepligenRGEN

$129.34—

SS&C TechnologiesSSNC

$97.28+43.3%

RepligenRGEN

$65.80-18.2%

VeriSignVRSN

$226.12+16.1%

Other financials

Income statement

See full

Revenue$995.8M+1.2%

Gross profit$349.0M-3.5%

Operating income$119.9M+60.6%

Net income-$14.8M-158%

EPS (diluted)-$0.30-160%

Balance sheet

See full

Cash & equivalents$198.2M-14.5%

Total debt$3.1B+1.9%

Total equity$2.9B-7.9%

Total assets$7.7B+2.0%

Cash flow

See full

Operating cash flow$41.1M-76.1%

CapEx$55.9M-5.8%

Free cash flow-$14.8M-113%

Valuation

See full

Market cap$8.91B+10.3%

Enterprise value$11.79B+8.5%

P/S2.2×+0.2×

Profitability

See full

Gross margin84.7%—

Operating margin13%-2.4pp

Net margin-4.6%—

FCF margin9.7%-4.3pp

Returns & leverage

See full

Return on equity-6%—

Debt / equity1×+0.1×

Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.

The official record: Charles River Laboratories’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Charles River Laboratories's share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value?: Charles River Laboratories (CRL) reported share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value of $61.63 in Q4 2025.
What does share based compensation arrangement by share based payment award options grants in period weighted average grant date fair value mean?: The weighted-average fair value of stock options granted during the period, calculated at the date of grant. This metric provides a standardized view of the cost per option awarded to employees.